Top compounds associated with response to MARCH11


Feature Type Standardized
Nominal ANOVA
mRNA AZD0530 CCLE pan-cancer AAC -0.22 0.0008
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.14 0.0008
mRNA TW 37 GDSC1000 pan-cancer AAC -0.13 0.0008
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.13 0.001
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.13 0.001
mRNA lovastatin CTRPv2 pan-cancer AAC -0.14 0.001
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.001
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.13 0.001
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.12 0.001
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.001
Download CSV